Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

finchimica s.p.a. - pendimethalin; liquid hydrocarbon - emulsifiable concentrate - pendimethalin anilide/aniline-dinitro active 330.0 g/l; liquid hydrocarbon solvent other 557.0 g/l - herbicide - avocado | bahia grass | banana | barley - prior to sowing | bent grass | broccoli transplants | buffalo grass lawn or turf | cab - annual or wimmera ryegrass | annual sedge - suppression | asthma plant | awnless barnyard grass | barnyard or water grass | bathurst burr | bittercress or swinecress | blackberry nightshade | blackberry nightshade - suppression | bladder ketmia | blue top - ageratum/heliotropium spp. | brown beetle or silver top grass | button grass | caltrop or yellow vine | caltrop or yellow vine - suppression | capeweed - suppression | chickweed | cobbler's pegs | common heliotrope | common sowthistle - suppression | common verbena - supression | crested goosefoot | crowsfoot grass | curious weed | deadnettle | dock - seedling | dwarf amaranth or boggabri weed | early spring grass | erodium spp. - suppression | fat hen | fumitory | green amaranth | green fat hen | green summer grass | guinea grass | indian hedge mustard | liverseed or urochloa grass | mintweed | mintweed - suppression | mossman river or burr grass | native millet | nettle | noogoora burr | paddy melon | pale pigeon grass | paspalidium | pepper grass | pepp

Australia - English - Department of Health (Therapeutic Goods Administration)

janssen-cilag pty ltd - daratumumab, quantity: 400 mg - injection, concentrated - excipient ingredients: glacial acetic acid; sodium acetate trihydrate; sodium chloride; mannitol; polysorbate 20; water for injections - darzalex is indicated for the treatment of patients:,? with newly diagnosed multiple myeloma:,- who are eligible for autologous stem cell transplant. for use in combination with:,? bortezomib, thalidomide, and dexamethasone.,- who are ineligible for autologous stem cell transplant. for use in combination with:,? bortezomib, melphalan and prednisone, or,? lenalidomide and dexamethasone.,? with multiple myeloma who have received:,- at least one prior therapy. for use in combination with:,? bortezomib and dexamethasone, or,? lenalidomide and dexamethasone.,- at least three prior lines of therapy including a proteasome inhibitor (pi) and an immunomodulatory agent or who are refractory to both a pi and an immunomodulatory agent. for use as:,? monotherapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

janssen-cilag pty ltd - daratumumab, quantity: 100 mg - injection, concentrated - excipient ingredients: glacial acetic acid; sodium acetate trihydrate; sodium chloride; mannitol; polysorbate 20; water for injections - darzalex is indicated for the treatment of patients:,? with newly diagnosed multiple myeloma:,- who are eligible for autologous stem cell transplant. for use in combination with:,? bortezomib, thalidomide, and dexamethasone.,- who are ineligible for autologous stem cell transplant. for use in combination with:,? bortezomib, melphalan and prednisone, or,? lenalidomide and dexamethasone.,? with multiple myeloma who have received:,- at least one prior therapy. for use in combination with:,? bortezomib and dexamethasone, or,? lenalidomide and dexamethasone.,- at least three prior lines of therapy including a proteasome inhibitor (pi) and an immunomodulatory agent or who are refractory to both a pi and an immunomodulatory agent. for use as:,? monotherapy.

Australia - English - Department of Health (Therapeutic Goods Administration)

janssen-cilag pty ltd - daratumumab, quantity: 1800 mg - injection, solution - excipient ingredients: vorhyaluronidase alfa; histidine; histidine hydrochloride monohydrate; sorbitol; methionine; polysorbate 20; water for injections - darzalex sc is indicated for the treatment of patients:,? with newly diagnosed multiple myeloma:,- who are eligible for autologous stem cell transplant. for use in combination with:-bortezomib, thalidomide, and dexamethasone.,- who are ineligible for autologous stem cell transplant. for use in combination with: - bortezomib, melphalan and prednisone, or - lenalidomide and dexamethasone.,? with multiple myeloma who have received: - at least one prior therapy. for use in combination with: - bortezomib and dexamethasone, or - lenalidomide and dexamethasone.,- at least three prior lines of therapy including a proteasome inhibitor (pi) and an immunomodulatory agent or who are refractory to both a pi and an immunomodulatory agent. for use as: - monotherapy.,darzalex sc in combination with bortezomib, cyclophosphamide and dexamethasone, is indicated for the treatment of patients with light chain al amyloidosis.

Israel - English - Ministry of Health

j-c health care ltd - darunavir as ethanolate - film coated tablets - darunavir as ethanolate 400 mg - darunavir - darunavir - prezista , co-administered with 100 mg ritonavir (prezista/rtv), and with other antiretroviral agents, is indicated for the treatment of human immunodeficiency virus (hiv-1) infection for over 18 years of age.

Israel - English - Ministry of Health

j-c health care ltd - darunavir as ethanolate - film coated tablets - darunavir as ethanolate 600 mg - darunavir - darunavir - prezista , co-administered with 100 mg ritonavir (prezista/rtv), and with other antiretroviral agents, is indicated for the treatment of human immunodeficiency virus (hiv-1) infection for over 18 years of age.

Ireland - English - HPRA (Health Products Regulatory Authority)

amdipharm limited - erythromycin - granules for oral suspension - 125 mg/5ml - macrolides; erythromycin

Australia - English - Department of Health (Therapeutic Goods Administration)

aurobindo pharma australia pty ltd - levetiracetam -

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - mycophenolate mofetil -

Australia - English - Department of Health (Therapeutic Goods Administration)

actavis australia pty ltd - oxaliplatin -